Diferencia entre revisiones de «Pyrantel Pamoate»
(Text replacement - "* " to "*") |
|||
| Línea 44: | Línea 44: | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:ID]] | |||
Revisión actual - 22:10 23 sep 2019
Administration
- Type: Antiparasitic
- Dosage Forms:
- Routes of Administration: Oral
- Common Trade Names:
Adult Dosing
- 11mg/kg once
Pediatric Dosing
- > 2yo: 11mg/kg once
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing:
- Hepatic dosing:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
- Nausea/vomiting, diarrhea
- Headache, dizziness, somnolence
Pharmacology
- Half-life:
- Metabolism:
- Excretion: Fecal
Mechanism of Action
- depolarizing neuromuscular blocking agent, causes spastic paralysis in the worms
Comments
- Indicated to treat infection with enterobius, ascaris, and other similar worms